|
|
||||||||||||||
|
|
|||||||||||||||
encan Özmee, Ay
e Karadumanc, Ersin Tanf, J Andoni Urtizbereag, Jacques S Beckmannd, Haluk Topalo
luc
a Department of
Medical Biology, Hacettepe University Medical School, 06100 Ankara,
Turkey, b Department of Paediatric Pathology, Hacettepe
University Medical School, 06100 Ankara, Turkey, c Department of Paediatric
Neurology, Hacettepe University Medical School, 06100 Ankara, Turkey, d Genethon,
1 rue de l'Internationale, 91002 Evry Cedex, France, e Department of Paediatric
Cardiology, Hacettepe University Medical School, 06100 Ankara, Turkey, f Department of Neurology,
Hacettepe University Medical School, 06100 Ankara, Turkey, g Institute de Myologie - AFM7, Groupe Hospitalier
Pitié-Salpetriére, 47-83 Boulevard de l'Hopital, 75651 Paris Cedex
13, France
Correspondence to: Dr
Topalo
lu, National Institutes of Health, NINDS, DMNB, Building
10, Room 3D 03, 10 Center Drive, Bethesda, MD 20892-1260, USA,
htopalog{at}codon.nih.gov
Revised version received 1 December 1999;
Accepted for publication 14 December
1999
Limb-girdle muscular dystrophies constitute a broad range of
clinical and genetic entities. We have evaluated 38 autosomal recessive
limb-girdle muscular dystrophy (LGMD2) families by linkage analysis for
the known loci of LGMD2A-F and protein studies using immunofluorescence
and western blotting of the sarcoglycan complex. One index case in each
family was investigated thoroughly. The age of onset and the current
ages were between 11/2 and 15 years and 6 and
36 years, respectively. The classification of families was as follows:
calpainopathy 7, dysferlinopathy 3,
sarcoglycan deficiency 2,
sarcoglycan deficiency 7,
sarcoglycan deficiency 5,
sarcoglycan
deficiency 1, and merosinopathy 2. There were two families showing an
Emery-Dreifuss phenotype and nine showing no linkage to the LGMD2A-F
loci, and they had preserved sarcoglycans.
sarcoglycan deficiency seems to be the most severe group as a
whole, whereas dysferlinopathy is the mildest. Interfamilial variation
was not uncommon. Cardiomyopathy was not present in any of the
families. In sarcoglycan deficiencies, sarcoglycans other than the
primary ones may also be considerably reduced; however, this may not be
reflected in the phenotype. Many cases of primary
sarcoglycan
deficiency showed normal or only mildly abnormal
sarcoglycan staining.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |